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The nucleolus is a suborganelle within the nucleus andwas one of the
ﬁrst intracellular structures identiﬁed by simple light microscopy back in
the mid-1800s [1]. Nucleoli are disassembled during cell division and re-
formed at the end of mitosis around chromosomal regions termed
nucleolar organizing regions consisting of tandem repeats of ribosomal
DNA (rDNA) [2,3]. With the identiﬁcation of ribosomal RNA (rRNA) and
proteins within the nucleolus, the organelle was determined as the site
for nascent ribosomal biogenesis and assembly, nearly a century after its
initial discovery [1,2]. Over the past few decades however, the nucleolus
has been associated with many diverse cellular functions. Of 4500
nucleolar proteins discovered, approximately 30% are linked to ribosomal
assembly and processing [3,4] and a predominant population of nucleolar
proteins play vital roles in cell cycle control, signal recognition particle
assembly, cell growth, microRNA biogenesis, viral replication, cell death,
nuclear transport, stem cell fate and commitment, cellular senescence,
and stress response signaling in eukaryotic cells [1,2,5–10]. This review
discusses the role of the nucleolus and nucleolar proteins in regulating
cardiovascular pathophysiology.2. Nucleolus as a stress sensor in cardiac disease
The mammalian nucleolus is normally tripartite having three mor-
phologically distinct subcompartments, the ﬁbrillar center, the dense
ﬁbrillar component and the granular component (Fig. 1) [1,2,11].
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architecture (Fig. 2) [3,12]. Nucleolar enlargement is indicative of
increased protein synthesis and growth and is one of the early
changes observed in hypertrophied human hearts [13,14]. Neonatal
rat cardiac myocytes treated with phenylephrine, an α1-adrenergic
receptor agonist and stressed cardiac myocytes in the border zone of
a myocardial infarction (MI) also display enlarged, irregularly
shaped nucleoli [15]. An increase in nucleolar size concomitantly
associated with alterations in the ultrastructure is observed during
ischemic and dilated cardiomyopathies in humans, wherein nucleoli
become less granular and more ﬁbrillar, suggestive of increased
ribosomal activity [16]. Nucleolar hypertrophy also results from
polyploidy and endoreduplication of chromosomes [13]. Disruption of
the nucleolus is common in response to DNA damage, genotoxic stress,
change in temperature, hypoxia, and treatmentwith chemotherapeutic
drugs that inhibit transcription and ribosomal subunit processing
[3,12,17,18]. The nucleolus shrinks, segregates (separation of granular
component and ﬁbrillar center upon compaction of the nucleolus)
[19] or fragments (decondensation and unraveling of rDNA) [12]
upon receiving cues for increased cellular stress. Treatment with
chemotherapeutic drugs Actinomycin D and doxorubicin in cardiac
myocytes causes decondensation and shrinkage of the nucleolus
with delocalization of nucleolar stress sensor proteins [15]. Nucleolar
and ribosomal stress have been demonstrated to elicit p53 dependent
and independent signaling pathways to activate stress response signal-
ing, which in turn leads to increased apoptosis, cell cycle arrest or
senescence in a cell type and stimulus dependent manner [3,17,20,21].
3. Nucleolar organizing regionas a determinant of cardiac pathology
Nucleolar organizing regions (NORs) are tightly aggregated
chromosomal DNA involved in transcription of rRNA and present in
the nucleoli of cells in interphase [22–24]. Since NORs contain acidic,
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Fig. 1. The nucleolus is tripartite and has 3 subcompartments— Fibrillar center (FC, black),
dense ﬁbrillar component (DFC, red) and granular compartment (GC, green).
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staining with silver (Ag) acetate enables easy visualization of NORs
(termed Ag-NOR) [24]. Ag-NORs which are identiﬁed as black dots
under the light microscope correspond to the proteins in the ﬁbrillar
center and dense ﬁbrillar component and correlate with cellular
proliferation rate in cancer cells [24,25]. Activity of cardiac NORs
correlates positively with myocardial weight, left ventricular wall
thickness and maximal diastolic pressure in hypertensive hearts [26],
suggestive of increased NOR and nucleolar activity during hypertrophy
[13]. Ag-NORs are decreased in cardiomyocytes of hearts with severe
ischemia and heart failure, owing to decreased metabolic activity and
diminished rRNA synthesis [26,27]. Cardioplegia or temporary cardiac
arrest also decreases Ag-NORs, while reperfusion increases them
[27,28]. Doxorubicin induced cardiotoxicity increases number of Ag-
NORs, but also causes them to be morphologically altered (enlarged
and rod shaped compared to small round dots) [22]. Collectively,
these observations imply that NORs function as highly sensitive
indicators of cardiac function and disease.
The following section will detail the role played by evolutionarily
conserved nucleolar proteins in regulation of cardiovascular diseases.Nucleus
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Fig. 2. The nucleolus functions as a stress sensor and responds by undergoing enlargement or di
nucleolar stress are listed based on the effect seen (see text for details). Nucleolar subcompartAlthough amyriad of proteins translocate into the nucleolus in response
to stress signaling and either activate or attenuate different signal
transduction pathways, for purposes of this review, we will focus only
on four proteins which are predominantly localized to and function
mainly within the nucleolus.
4. Nucleolar proteins associated with cardiac pathophysiology
4.1. Nucleolin
Nucleolin (Ncl or C23) is amultifunctional, nucleolar phosphoprotein
with important roles in ribosomal biogenesis, cell cycle regulation,
growth, cell death and signal transduction [29–31]. Ncl is mainly
associated with cell growth and pro-survival responses in the heart,
consistent with loss of proliferation and increased apoptosis observed
upon Ncl downregulation in C2C12 skeletal myoblasts [32]. Tran-
scriptional regulation of Ncl occurs in rat cardiac myocytes during
development and early postnatal growth, when cardiomyocytes retain
their limited proliferative potential. However, translation but not
transcription is increased in cardiac myocytes during hypertrophic
growth indicating differential regulation of Ncl in response to
hyperplastic and hypertrophic stimuli [33]. Ncl is required for cell
survival and mediates the antiapoptotic effects downstream of heat
shock protein 70 upon oxidative stress in cardiac myocytes [34].
Transgenic mice with cardiac speciﬁc overexpression of Ncl are resistant
to ischemia–reperfusion injury and have reduced infarction size and cell
death [35]. The important role played by Ncl in regulating cell
proliferation and survival also has implications in heart diseases in
humans. Patients receiving heart transplant show 9 fold higher levels
of antibodies against Ncl, suggesting that Ncl inhibition is associated
with coronary artery disease and allograft failure in heart transplant
patients owing to increased apoptosis and decreased endothelial cell
proliferation [36]. Although predominantly nucleolar, Ncl translocates
to the nucleoplasm, cytoplasm and cell surface in proliferating
endothelial cells [37,38]. Antibodies against cell surface Ncl inhibit
angiogenesis in vitro and in vivo [38,39]. Increases in Ncl protein
expression and nucleolar localization are observed during ischemic and
dilated cardiomyopathies, which also correlate with altered left
ventricular dimensions and cardiac function [16]. Therefore as a pro-
survival and pro-growth molecule, Ncl is involved in regulating the
structure and function of the heart.• Cardiac 
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Nucleostemin (NS) also known as guanine nucleotide-binding like 3
(gnl3) is highly enriched in cancer and stem cells and has a conserved
role in regulating proliferation and cell cycle progression [5,40–43]. NS
has been implicated in pre-rRNA processing and ribosomal biogenesis
[44–46], although an initial study identiﬁed NS to be predominantly
localized to the granular component of the nucleolus, away from the
site of rRNA biogenesis (which occurs in the ﬁbrillar center and dense
ﬁbrillar compartment) [47]. Maintenance of stem cell pluripotency,
regulation of telomere length, inhibition of stem cell differentiation,
senescence and cell death are among the pivotal roles played by NS
[5,48–52]. Our group has been actively studying the role of NS in the
heart and cardiac cells for the past few years [15,53]. NS expression is
increased during cardiac development and declines rapidly after birth
with age. Cultured neonatal cardiac myocytes and c-kit + cardiac
progenitor cells (CPCs) with increased proliferative potential express
high levels of NS. NS expression is lost upon commitment of CPCs, but
is re-induced upon cardiac injury in the nucleoli of CPCs and cardiac
myocytes in the border zone of the ischemic heart [53]. Pressure
overload induced cardiac hypertrophy and mouse models of chronic
dilated cardiomyopathy also display elevated NS levels, suggesting a
role for NS in proliferative and survival signaling in the heart [15,53].
Consistently, loss of NS increases cell death in response to DNA damage
[15]. NS has been linked with maintenance of nucleolar architecture in
cancer cells [54], but our ﬁndings demonstrate a more compelling role
for an interacting partner of NS in the maintenance of nucleolar
integrity in cardiac cells [15] (described in detail below). NS also
preserves telomere length in CPCs by increasing expression of
telomerase reverse transcriptase and proteins that positively regulate
telomere length [53]. NS is required for cell cycle progression,
maintenance of CPC stemness and antagonizing cardiac senescence
(Hariharan N and Sussman MA, unpublished results). Multifunctional
roles in stem cell biology make NS an ideal candidate to enhance
myocardial regeneration and antagonize aging.
4.3. Nucleophosmin
Nucleophosmin (NPM or B23) also is a nucleolar phosphoprotein
that functions as a histone chaperone [55,56]. NPM regulates cell
survival and proliferation and is required for maintenance of DNA
integrity and chromosome stability [55,57]. Mutations in NPM gene
affect growth characteristics in large mammals [58,59]. Importantly,
NPM functions as a nucleolar stress sensor in noncardiac [60,61] and
cardiac cells [15], as demonstrated previously by our group.
Delocalization of NPM and NS is an early response to transcriptional
and genotoxic stress stimuli in cardiac myocytes and in the adult
mouse heart [15]. Interestingly however NPM, but not NS, is required
for maintenance of nucleolar architecture in CPCs [15]. Loss of NPM
causes nucleolar fragmentation, inhibits pre-rRNA synthesis and
induces apoptosis in cardiac progenitor cells and myocytes, while
activating p53mediated stress response signaling [15]. NPM expression
increases in mouse hearts after myocardial infarction and pressure
overload-induced hypertrophy, however a select group of myocytes in
the border zone of MI and hypoxic myocytes in vitro undergoing
nucleolar stress exhibit delocalization of NPM and NS [15]. NPM is also
identiﬁed as one of the genes that is upregulated 2 fold in the atria of
dogs fed with high fat diet to induce obesity-related hypertension
[62,63]. The important role of NPM in regulating cell proliferation and
growth suggests that NPM could be contributory to early remodeling
during atrial hypertension [62]. NPM also regulates activity of nuclear
factor kappa-light chain enhancer of activated B cells (NF-kB) in
endothelial cells during aging [64,65]. Expression of NPM mRNA
increases in carotid arteries and hearts of aged rats, concomitantly
associated with increased NF-kB activity, implying a role for NPM in
regulating oxidative stress response and proinﬂammatory pathwaysassociated with cardiovascular aging [64]. Studies also link NPM to the
onset of atherosclerosis. Human vascular endothelial cells treated with
oxidized low density lipoprotein show dephosphorylated levels of
NPM correlating with decreased proliferation and increased cellular
dysfunction [66], consistent with studies demonstrating enhanced
endothelial cell proliferation correlating to increased NPM phospho-
rylation upon treatment with cardioprotective drugs [67].
4.4. Fibrillarin
Fibrillarin (Fbl) is a methyl transferase enzyme that is a component
of different ribonucleoproteins, including nucleolar small nuclear
ribonucleoprotein (snRNP) and small nucleolar ribonucleoproteins
(snoRNP) [68–70]. Located in the dense ﬁbrillar compartment of the
nucleolus, Fbl is involved in the initial steps of pre-rRNA processing
and is essential for embryogenesis and small nucleolar RNA (snoRNA)
synthesis [68,69,71]. Fbl is associated with NCl in the formation of
NORs, and in the rapid change in NOR numbers during conditions like
cardioplegia and reperfusion in humans undergoing heart surgery
[28]. Autoantibodies against Fbl are generated during systemic sclerosis,
an autoimmune disease characterized by increased ﬁbrosis in the skin
and visceral organs like the heart. Presence of Fbl antibodies predicts
the extent of the disease and identiﬁes patients with renal disease,
pulmonary hypertension and myositis as a consequence of systemic
sclerosis [72].
5. Conclusion
The nucleolus is at the hub of proliferative, prosurvival and growth
response signaling. However, the effects played by nucleolar proteins
have been largely overlooked in the cardiac context. Cardiac-speciﬁc
conditional knockout mice models of nucleolar proteins are yet to be
created and characterized. Detailed studies on the role and function of
nucleolar proteins and the nucleolus will provide mechanistic insights
into several cardiovascular diseases andmayhold the key to therapeutic
options in the future.
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